Related Experiment Video
Updated: Aug 26, 2025

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance
Mehrdad Hashemi1, Sahar Hasani2, Shima Hajimazdarany3
1Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Farhikhtegan Medical Convergence sciences Research Center, Farhikhtegan Hospital Tehran Medical sciences, Islamic Azad University, Tehran, Iran.
Abstract:
Cancer is a challenging to treat disease with a high mortality rate worldwide, nevertheless advances in science has led to a decrease in the number of death cases caused by cancer. Aberrant expression of genes occurs during tumorigenesis therefore targeting the signaling pathways that regulate these genes' expression is of importance in cancer therapy. Notch is one of the signaling pathways having interactions with other vital cell signaling molecules responsible for cellular functions such as proliferation, apoptosis, invasion, metastasis, epithelial-to-mesenchymal transition (EMT), angiogenesis, and immune evasion. Furthermore, the Notch pathway is involved in response to chemo- and radiotherapy. Thus, targeting the Notch signaling pathway in cancer therapy can be beneficial for overcoming the therapeutic gaps. Non-coding RNAs (ncRNAs) are a class of RNAs that include short ncRNAs (such as micro RNAs) and long ncRNAs (lncRNAs). MicroRNAs (miRNAs) are ~22 nucleotides in length while lncRNAs have more than 200 nucleotides. Both miRNAs and lncRNAs control vital cellular mechanisms in cells and affect various signaling pathways and Notch is among them. The current review aims to discuss the critical role of ncRNAs in the regulation of the Notch signaling pathway by focusing on different cancer hallmarks including proliferation, apoptosis, autophagy, EMT, invasion, metastasis, and resistance to therapies.
Insights
Non-coding RNAs (ncRNAs) regulate the Notch signaling pathway, impacting cancer hallmarks like proliferation and metastasis. Understanding this interaction is key for developing novel cancer therapies.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Cancer remains a leading cause of death globally, necessitating innovative therapeutic strategies.
- Aberrant gene expression in tumorigenesis highlights the importance of targeting regulatory signaling pathways.
- The Notch signaling pathway plays a crucial role in cellular functions and cancer progression, including proliferation, apoptosis, invasion, metastasis, epithelial-to-mesenchymal transition (EMT), angiogenesis, and immune evasion.
Purpose of the Study:
- To review the critical role of non-coding RNAs (ncRNAs) in regulating the Notch signaling pathway.
- To explore how ncRNAs influence key cancer hallmarks.
- To discuss the implications of ncRNA-Notch pathway interactions in cancer therapy and resistance.
Main Methods:
- Literature review focusing on ncRNAs (microRNAs and long non-coding RNAs) and their interaction with the Notch pathway.
- Analysis of studies investigating the role of ncRNAs in cancer hallmarks.
- Examination of evidence linking ncRNA-mediated Notch regulation to therapeutic resistance.
Main Results:
- ncRNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), are key regulators of the Notch signaling pathway.
- Dysregulation of ncRNAs impacts various cancer hallmarks such as proliferation, apoptosis, autophagy, EMT, invasion, and metastasis.
- ncRNAs influence cellular responses to chemo- and radiotherapy by modulating Notch signaling, contributing to therapeutic resistance.
Conclusions:
- ncRNAs are significant modulators of the Notch pathway in cancer.
- Targeting ncRNA-mediated regulation of Notch signaling presents a promising avenue for overcoming therapeutic resistance and improving cancer treatment outcomes.
- Further research into ncRNA-Notch interactions is essential for developing effective cancer therapies.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Non-Canonical Wnt Signaling Pathways
lncRNA - Long Non-coding RNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Canonical Wnt Signaling Pathway

